Drug Type Small molecule drug |
Synonyms S95035 |
Target |
Mechanism Mat2A inhibitors(S-adenosylmethionine synthase isoform type-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Servier Pharmaceuticals LLCStartup |
Active Organization Servier Pharmaceuticals LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | FR | Servier Pharmaceuticals LLCStartup | - |